Telecom & Wireless
The Worst Stocks Of The Week (SVU, WMT, MRK, VZ, S, T, AAPL)
Published:
Last Updated:
| S&P 500 WEEK: BOTTOM 10 (07 JAN-13 JAN) | Ticker | Weekly Price Change (%) | Close Price 13Jan11 | Close Price 07Jan11 | Market Cap($Mil) |
| SUPERVALU INC. | SVU | -13.4 | 7.50 | 8.66 | 1591.3 |
| Merck & Co Inc. | MRK | -7.1 | 34.69 | 37.35 | 106875.8 |
| RadioShack Corp | RSH | -6.6 | 17.14 | 18.36 | 1951.0 |
| American International Group Inc | AIG | -6.5 | 57.19 | 61.18 | 38439.6 |
| Advanced Micro Devices Inc | AMD | -6.5 | 8.26 | 8.83 | 5631.4 |
| Monster Worldwide Inc. | MWW | -6.2 | 23.51 | 25.07 | 3057.1 |
| Washington Post Co | WPO | -4.8 | 421.30 | 442.56 | 3035.9 |
| Omnicom Group Inc. | OMC | -4.6 | 44.84 | 47.00 | 13507.6 |
| Sprint Nextel Corp | S | -4.3 | 4.48 | 4.68 | 13225.2 |
| Intuit Inc. | INTU | -4.2 | 46.36 | 48.39 | 14399.9 |
Source: Capital IQ
Shares of grocery store giant Supervalu (NYSE: SVU) collapsed as the firm’s earnings were well below expectations. High commodities prices and competition from big box retailers such as Wal-Mart (NYSE: WMT) have finally caught up to Supervalu. The problems are not going to go away. The prices of agricultural products from corn to soy beans have reached all time highs. Supervalu is not going to be able to pass all of those costs of goods on to its customers.
Merck (NYSE: MRK) shares fell as it joined other large pharmaceutical companies which have been unable to replace their aging blockbuster drugs with new ones. Trials for anticlotting drup vorapaxar did not show promising results. Merck believed vorapaxar would eventually have annual sales of $5 billion. Now, vorapaxar may never produce any revenue at all. According to Bloomberg, “All participants will stop taking the drug in the trial of 13,000 patients who began the medicine at the time of a heart attack or chest pain, researchers at Brigham & Women’s Hospital in Boston and the Duke Clinical Research Institute in Durham, North Carolina, said today. A second study, of 26,500 patients with prior heart problems, will be stopped for the 25 percent who had suffered a stroke.”
Sprint-Nextel (NYSE: S) shares dropped over 4% for the week. It has occurred to investors now that the Apple (NASDAQ: AAPL) iPhone will be sold by Verizon Wireless (NYSE: VZ) and AT&T (NYSE: T), Sprint subscribers will continue to migrate to competitors to get the superphone. Sprint’s WiMax 4G service is about to be challenged by LTE technology from AT&T and Verizon. Sprint has been painted into a corner.
Douglas A. McIntyre
Take Charge of Your Retirement In Just A Few Minutes (Sponsor)
Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s made it easier than ever for you to connect with a vetted financial advisor.
Here’s how it works:
- Answer a Few Simple Questions. Tell us a bit about your goals and preferences—it only takes a few minutes!
- Get Matched with Vetted Advisors Our smart tool matches you with up to three pre-screened, vetted advisors who serve your area and are held to a fiduciary standard to act in your best interests. Click here to begin
- Choose Your Fit Review their profiles, schedule an introductory call (or meet in person), and select the advisor who feel is right for you.
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.